Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Therapeutic Advances in Medical Oncology
|
January 11, 2024
Deficient mismatch repair/microsatellite unstable colorectal cancer: therapeutic advances and questions
Baptiste Cervantes, Thierry André, Romain Cohen
Bulletin Du Cancer
|
November 8, 2024
[Claudine 18.2: A new therapeutic target in digestive cancers]
Laure Blondet, Baptiste Cervantes, Florence Renaud, et al.
Bulletin Du Cancer
|
December 19, 2022
Marine Valéry, Baptiste Cervantes, Cristina Smolenschi, et al.
Bulletin Du Cancer
|
March 29, 2024
[An update on total neoadjuvant treatment of adenocarcinoma of the rectum]
Maroussia Medioni, Baptiste Cervantes, Florence Huguet, et al.
Clinical Colorectal Cancer
|
June 12, 2026
Dual CTLA-4/PD-1 Blockade Versus Anti-PD-1 in MSI-H Metastatic Colorectal Cancer: Early Survival Benefit and Exploratory Clinical Predictors
Lea Jehanno, Julie Henriques, Thomas Samaille, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 20, 2025
Patterns of progressive disease in patients with microsatellite instability-high (MSI-H) metastatic colorectal cancer treated with immune checkpoint inhibitor(s): Different entities requiring tailored management
Baptiste Cervantes, Clément Grosnon, Thomas Samaille, et al.
Langenbeck'S Archives of Surgery
|
March 29, 2022
Prognostic role of infracentimetric colorectal liver metastases
Fabio Frosio, Baptiste Cervantes, Alexandra Nassar, et al.
Cancers
|
September 23, 2022
Immunotherapy and Hepatocellular Cancer: Where Are We Now?
Marine Valery, Baptiste Cervantes, Ramy Samaha, et al.
The Oncologist
|
April 6, 2023
BRAF V600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors
Raphael Colle, Sara Lonardi, Marine Cachanado, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 19, 2024
Imaging-guided prognostic score-based approach to assess the benefits of combotherapy versus monotherapy with immune checkpoint inhibitors in metastatic MSI-H colorectal cancer patients
Rémy Barbe, Younes Belkouchi, Yves Menu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Therapeutic Advances in Medical Oncology
|
January 11, 2024
Deficient mismatch repair/microsatellite unstable colorectal cancer: therapeutic advances and questions
Baptiste Cervantes, Thierry André, Romain Cohen
Bulletin Du Cancer
|
November 8, 2024
[Claudine 18.2: A new therapeutic target in digestive cancers]
Laure Blondet, Baptiste Cervantes, Florence Renaud, et al.
Bulletin Du Cancer
|
December 19, 2022
Marine Valéry, Baptiste Cervantes, Cristina Smolenschi, et al.
Bulletin Du Cancer
|
March 29, 2024
[An update on total neoadjuvant treatment of adenocarcinoma of the rectum]
Maroussia Medioni, Baptiste Cervantes, Florence Huguet, et al.
Clinical Colorectal Cancer
|
June 12, 2026
Dual CTLA-4/PD-1 Blockade Versus Anti-PD-1 in MSI-H Metastatic Colorectal Cancer: Early Survival Benefit and Exploratory Clinical Predictors
Lea Jehanno, Julie Henriques, Thomas Samaille, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 20, 2025
Patterns of progressive disease in patients with microsatellite instability-high (MSI-H) metastatic colorectal cancer treated with immune checkpoint inhibitor(s): Different entities requiring tailored management
Baptiste Cervantes, Clément Grosnon, Thomas Samaille, et al.
Langenbeck'S Archives of Surgery
|
March 29, 2022
Prognostic role of infracentimetric colorectal liver metastases
Fabio Frosio, Baptiste Cervantes, Alexandra Nassar, et al.
Cancers
|
September 23, 2022
Immunotherapy and Hepatocellular Cancer: Where Are We Now?
Marine Valery, Baptiste Cervantes, Ramy Samaha, et al.
The Oncologist
|
April 6, 2023
BRAF V600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors
Raphael Colle, Sara Lonardi, Marine Cachanado, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 19, 2024
Imaging-guided prognostic score-based approach to assess the benefits of combotherapy versus monotherapy with immune checkpoint inhibitors in metastatic MSI-H colorectal cancer patients
Rémy Barbe, Younes Belkouchi, Yves Menu, et al.
Page
of 2